thiazoles has been researched along with isothiafludine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, HJ; Feng, CL; Hao, YH; He, PL; Nan, FJ; Shi, LP; Tang, W; Tong, XK; Wang, BJ; Wang, GF; Wang, WL; Yang, DL; Yang, L; Zhang, YM; Zhu, FH; Zuo, JP | 1 |
| Chen, HJ; Feng, CL; He, PL; Lu, MJ; Nan, FJ; Shi, LP; Tang, W; Tong, XK; Wang, GF; Wang, WL; Wang, YJ; Xu, YB; Yang, L; Zhang, YM; Zuo, JP | 1 |
| Wang, D | 1 |
3 other study(ies) available for thiazoles and isothiafludine
| Article | Year |
|---|---|
Isothiafludine, a novel non-nucleoside compound, inhibits hepatitis B virus replication through blocking pregenomic RNA encapsidation.
Topics: Animals; Antiviral Agents; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Resistance, Multiple, Viral; Ducks; Hep G2 Cells; Hepadnaviridae Infections; Hepatitis B virus; Hepatitis B Virus, Duck; Hepatitis, Viral, Animal; Humans; Mutation; Nucleocapsid; RNA, Viral; Thiazoles; Time Factors; Transfection; Virus Replication | 2014 |
Effect of a hepatitis B virus inhibitor, NZ-4, on capsid formation.
Topics: Amino Acid Sequence; Capsid; Cell Line, Tumor; DNA, Viral; Endoribonucleases; Genome, Viral; Hep G2 Cells; Hepatitis B Core Antigens; Hepatitis B virus; Humans; Molecular Sequence Data; Phosphoprotein Phosphatases; RNA-Binding Proteins; RNA, Viral; Thiazoles; Virus Replication | 2016 |
Evaluation and improvement of LAMP assays for detection of
Topics: Bacteriological Techniques; DNA, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Feces; Genes, Bacterial; Humans; Nucleic Acid Amplification Techniques; O Antigens; Real-Time Polymerase Chain Reaction; Sensitivity and Specificity; Serogroup; Thiazoles | 2017 |